Independent validation of the PAM50-based Chemo-Endocrine Score (CES) in hormonal receptor positive (HR+)/HER2+ breast cancer (BC) treated with neoadjuvant anti-HER2-based therapy.
- Citation:
- Cancer Res vol 78 (4 Supplement) P2-09-05
- Meeting Instance:
- SABCS 2017
- Year:
- 2018
- Type:
- Abstract
- Sub type:
- Poster Discussion
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- 3314
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, BCRF
- Corr. Author:
- Authors:
- Tomás Pascual Maki Tanioka M.Vittoria Dieci Sonia Pernas Joaquin Gavila Valentina Guarnieri Javier Cortes Antonio Llombart Mafalda Oliveira Laia Paré Donald Berry Patricia Galvan Steven Isakoff Charles M. Perou Aleix Prat Lisa Carey
- Networks:
- LAPS-MA036, LAPS-NC007
- Study
- CALGB-40601
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: